Categories Uncategorized

Research Shows the Gut Is Pivotal in Protecting Brain from Microbes

The “Nature” journal published a research study last week that highlights the discovery of meninges to be home to plasma cells, which are immune cells that secrete antibodies. These cells are positioned near large blood vessels running in the meninges, which allows them to secrete antibodies that defend the brain’s perimeter.

For a long time, scientists couldn’t decipher how the brain remained protected against invading viruses and bacteria. However, a team of researchers led by scientists at the National Institute of Health in the United States and the University of Cambridge in the United Kingdom, have discovered that the specific antibody type produced by these cells was the type found in the intestine.

Plasma cells originate from an immune cell known as a B cell. Each B cell has a surface antibody unique to that specific cell. If an antigen, i.e., a virus or bacterium that triggers an immune response, binds to the antibody on its surface, the B cell activates. It will do this by dividing to create a new offspring that also recognizes the same antigen.

During division, a mutation is introduced into the antibody gene by the B cell that changes the binding characteristics of an amino acid. Several B cells then produce antibodies that allow better binding to the pathogen. These continue to expand and multiply, with B cells having antibodies that aren’t good at binding ultimately being eliminated. This helps make sure that the body produces the best antibodies for picking out and eliminating particular antigens.

Antibodies found in the meninges include immunoglobulin A, which is normally made in the lining of the lungs, nose or gut. The team of researchers sequenced the plasma cells in the meninges and the gut as well as the antibody genes in the B cells. They discovered that these cells were related. Professor Menna Clatworthy, the lead scientist from the Department of Medicine at Cambridge explained that it had been a mystery to scientists how the brain protected itself from infections, so discovering that the line of its defense originated from the gut was surprising.

The researchers made this discovery using mice, which are commonly used to study physiology because they share characteristics similar to humans. The findings of the study demonstrate that the immunoglobulin A cells were absent in the meninges when mice had no bacteria present in their guts. When the researchers removed plasma cells from the meninges, microbes spread into the brain from the bloodstream.

The team then analyzed samples that had been extracted during surgery and confirmed that immunoglobulin cells were present in human meninges, thus showing that this defense system played an important role in defending people from infections of the central nervous system, such as encephalitis and meningitis.

AzurRx BioPharma Inc. (NASDAQ: AZRX) is a clinical-stage biopharmaceutical firm that you should follow. The compamy focuses on using recombinant proteins to develop novel solutions for gastrointestinal diseases.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Breakthrough Treatment for Lung Cancer Uses Mitochondria to Supercharge Immune Cells

Researchers in China have discovered a way to supercharge the treatment of lung cancer by…

3 days ago

Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF): The Cancer Detection Revolution That Could Make Breast Cancer Deaths Preventable

Izotropic’s IzoView Breast CT Imaging System represents a breakthrough in dedicated breast imaging technology, addressing…

3 days ago

Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) Advancing Next-Gen Breast Cancer Imaging

Breast cancer continues to be the most commonly diagnosed cancer among U.S. women, excluding nonmelanoma…

4 days ago

How to Rebuild Trust in the US Healthcare System

A recent survey undertaken by Gallup in 2025 found that since 2021, there has been…

4 days ago

Lantern Pharma Inc. (NASDAQ: LTRN) Completes Japanese Enrollment for LP-300 Phase 2 HARMONIC(TM) Trial Ahead of Schedule

The trial targets never-smoker non-small cell lung cancer (“NSCLC”) patients, a group with limited treatment…

4 days ago

Lantern Pharma Inc. (NASDAQ: LTRN) Launches AI Tool to Predict Efficacy of Cancer Drug Combinations

Lantern Pharma has introduced an AI-powered module within its RADR(R) platform to assess DDA-DDRi combination…

5 days ago